Rapid Aneurysm is an FDA-cleared imaging platform for cerebral aneurysm management that helps clinicians and hospitals prevent missed diagnoses, and more accurately assess, visualize, and measure growth. With Rapid Aneurysm, clinicians can ensure proper follow up and keep patients in the network.
Easily track and manage care with automated measurements, including changes in volume and morphology, and compare scans over time.
“A well-validated AI programme [Rapid Aneurysm] that detects cerebral aneurysms is expected to be an asset to radiologists. AI programmes that detect cerebral aneurysms on CTA have been shown to improve radiologists’ sensitivity for the detection of aneurysms.”
"Artificial intelligence aneurysm measurement tool [Rapid Aneurysm] finds growth in all aneurysms that ruptured during conservative management."